Table 7.
Multi-resistant organisms involved in hospital acquired infection
| Multi-resistant organism | Pre-COVID Apr–Jun 2019 | COVID Apr–Jun 2020 | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Growth site | Wound or tissue | Urine | Other | Total | Wound or tissue | Urine | Other | Total | |
| S. aureus MRSA1 | 6 | 0 | 2 | 8 | 7 | 0 | 1 | 8 | 16 |
| S. epidermidis Oxacillin resistant | 5 | 0 | 1 | 6 | 6 | 0 | 0 | 6 | 12 |
| S. epidermidis Multi-resistant | 3 | 0 | 0 | 3 | 2 | 0 | 0 | 2 | 5 |
| Enterococcus VRE2 | 1 | 1 | 0 | 2 | 1 | 0 | 2 | 3 | 5 |
| E. coli ESBL | 1 | 4 | 1 | 6 | 2 | 3 | 3 | 8 | 14 |
| Klebsiella ESBL3 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 2 |
MRSA: Methicillin-resistant Staphylococcus aureus, VRE: Vancomycin resistant enterococcus, ESBL: Extended spectrum Beta-lactamase